Therapeutic effect of prednimustine (LEO 1031) in various types of leukaemia
- 31 May 1977
- journal article
- clinical trial
- Published by Elsevier
- Vol. 13 (4-5) , 393-398
- https://doi.org/10.1016/0014-2964(77)90088-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Preliminary clinical and absorption studies with prednimustine in patients with mammary carcinomaPublished by Elsevier ,1975
- QUALITY AND QUANTITY OF SURVIVAL IN ACUTE MYELOID LEUKÆMIAThe Lancet, 1975
- L‐Asparaginase and Prednisolone Pretreatment Followed by Rubidomycin and Cytosine Arabinoside for Induction of Remission in Adult Patients with Acute Myeloblastic LeukaemiaScandinavian Journal of Haematology, 1975
- THERAPEUTIC EFFECT OF LEO 1031, AN ALKYLATING CORTICOSTEROID ESTER, IN LYMPHOPROLIFERATIVE DISORDERSActa Medica Scandinavica, 1975
- THERAPEUTIC EFFECT OF LEO 1031, AN ALKYLATING CORTICOSTEROID ESTER, IN LYMPHOPROLIFERATIVE DISORDERSActa Medica Scandinavica, 1975
- Treatment of Acute Myeloid Leukaemia with Daunorubicin, Cytosine Arabinoside, Mercaptopurine, L‐Asparaginase, Prednisone and Thioguanine: Results of Treatment with Five Multiple‐Drug SchedulesBritish Journal of Haematology, 1974
- Chemotherapy of Acute LeukemiaArchives of internal medicine (1960), 1974
- Cytarabine for Acute Leukemia in AdultsArchives of internal medicine (1960), 1974
- Cell killing effectiveness of an alkylating steroid (Leo 1031)Published by Elsevier ,1973
- Acute myelocytic leukemia in adultsCancer, 1972